Skip to content

Total debt at other companies

Establishment Labs logo
Establishment LabsESTA
$252.71M+12.0%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$20.76B-3.5%
Eli Lilly logo
Eli LillyLLY
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$39.4M0.0%
Gross profit$23.8M+1.6%
Operating income-$1.8M-13.4%
Net income-$2.4M+15.8%
EPS (diluted)-$0.03+40.0%

Balance sheet

See full
Cash & equivalents$16.7M+201%
Total equity$100.3M+31.5%
Total assets$192.0M-5.5%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$51.0K-97.3%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$311.81M+4.7%
Enterprise value$366.14M-6.0%
P/S2.1×+0.3×

Profitability

See full
Gross margin59.6%-0.3pp
Operating margin-7.8%-0.4pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.6×
Current ratio0.7×+0.2×

Where this comes from

Calculated from AirSculpt Technologies, Inc.’s reported figures.

Plus components not separately reported this period.

The official record: AirSculpt Technologies, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AirSculpt Technologies, Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AirSculpt Technologies, Inc.'s total debt?
AirSculpt Technologies, Inc. (AIRS) reported total debt of $71.02M in Q1 2026.
How has AirSculpt Technologies, Inc.'s total debt changed year-over-year?
AirSculpt Technologies, Inc.'s total debt decreased by 27.1% year-over-year, from $97.43M to $71.02M.
What is the long-term trend for AirSculpt Technologies, Inc.'s total debt?
Over 5 years (2020 to 2025), AirSculpt Technologies, Inc.'s total debt has grown at a 10.9% compound annual growth rate (CAGR), from $49.77M to $83.57M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.